The ARK Genomic Revolution ETF ARKG, +2.01% started a position in Burning Rock Biotech BNR, +10.69%, a Chinese cancer sequencing technology company that jumped 11% after reporting third-quarter results. The loss-making biotech saw its revenue edge up 2% in the third quarter and is planning two products for early-stage cancer patients next year. In other moves, two Ark funds sold nearly $23 million worth of Unity Software U, -0.78%, while the ARK Next Generation Internet ETF continued to boost its holding in Robinhood Markets HOOD, -3.12%.
This article was originally published by Marketwatch.com. Read the original article here.
